Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Orexigen Therapeutics (NASDAQ:OREX): The shares closed at $2.19, up $0.72, or 48.98%, on the day. Its market capitalization is $105.31 million. About the company: Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $5.29, up $0.82, or 18.34%, on the day. Its market capitalization is $128.77 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products.
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $14.58, up $1.58, or 12.15%, on the day. Its market capitalization is $2.78 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.
  • Regeneron Pharmaceuticals (NASDAQ:REGN): The shares closed at $70.28, up $5.93, or 9.22%, on the day. Its market capitalization is $6.44 billion. About the company: Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
  • Affymax, Inc. (NASDAQ:AFFY): The shares closed at $4.60, up $0.22, or 5.02%, on the day. Its market capitalization is $163.55 million. About the company: Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.

Losers (% price change)

  • Vical Incorporated (NASDAQ:VICL): The shares closed at $2.43, down $0.42, or 14.74%, on the day. Its market capitalization is $174.57 million. About the company: Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.
  • NuVasive, Inc. (NASDAQ:NUVA): The shares closed at $18.65, down $2.56, or 12.07%, on the day. Its market capitalization is $743.77 million. About the company: NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company’s products include Maximum Access Surgery (NYSE:MAS) and Fusion products.
  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $3.72, down $0.46, or 11%, on the day. Its market capitalization is $204.17 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies.
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $4.40, down $0.52, or 10.57%, on the day. Its market capitalization is $149.96 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals.
  • Skilled Healthcare Group (NYSE:SKH): The shares closed at $3.73, down $0.41, or 9.9%, on the day. Its market capitalization is $141.81 million. About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>